DexCom Inc
Change company Symbol lookup
Select an option...
DXCM DexCom Inc
LOW Lowe's Companies Inc
BAC Bank of America Corp
ECF Ellsworth Growth and Income Fund Ltd
EBF Ennis Inc
EARN Ellington Residential Mortgage REIT
DXC DXC Technology Co
DX Dynex Capital Inc
DVYE iShares Emerging Markets Dividend ETF
DUK Duke Energy Corp
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The Company is commercializing its fifth generation CGM system. The Company's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers).

Closing Price
$312.55
Day's Change
-0.77 (-0.25%)
Bid
--
Ask
--
B/A Size
--
Day's High
320.14
Day's Low
311.01
Volume
(Below Average)
Volume:
817,837

10-day average volume:
990,977
817,837

Display:

Providers:

UpdateCancel
6 providers
November 12, 2020
Dexcom Announces Upcoming Virtual Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming virtual investor conferences: Steve Pacelli, Executive Vice President Strategy and Corporate Development will present on behalf of...(BusinessWire)

November 03, 2020
Dexcom to Host Investor Day on December 9, 2020

DexCom, Inc. (NASDAQ:DXCM) announced today that it will host an Investor Day on December 9, from 8:30 AM until approximately 11:30 AM Pacific Standard Time (11:30 AM - 2:30 PM Eastern). The event, which will be held virtually, will include...(BusinessWire)

Dexcom to Host Investor Day on December 9, 2020

DexCom, Inc. (NASDAQ:DXCM) announced today that it will host an Investor Day on December 9, from 8:30 AM until approximately 11:30 AM Pacific Standard Time (11:30 AM - 2:30 PM Eastern). The event, which will be held virtually, will include...(BusinessWire)

October 27, 2020
Dexcom Reports Third Quarter 2020 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2020. Third Quarter 2020 Financial Highlights: Revenue grew 26% versus the same quarter of the prior year to $500.9 million U.S. revenue...(BusinessWire)

October 26, 2020
Dexcom Announces Retirement of Rick Doubleday and Pre-Announcement of Third Quarter 2020 Revenue

DexCom, Inc. (NASDAQ:DXCM) today announced that Rick Doubleday, Executive Vice President and Chief Commercial Officer, will retire at the end of 2020 in order to spend more time with his family. Rick joined Dexcom in 2009 and has built a world-class...(BusinessWire)

October 13, 2020
Dexcom Appoints Kyle Malady to Board of Directors

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Kyle Malady to its Board of Directors, effective immediately. Mr. Malady currently serves as executive vice president of...(BusinessWire)

October 07, 2020
Lilly and Dexcom team up on new program to help improve diabetes management

Eli Lilly and Company (NYSE: LLY) and DexCom, Inc. (NASDAQ: DXCM) announced today a joint program for U.S. healthcare providers (HCPs) about Lilly's new rapid-acting mealtime insulin Lyumjev(TM) (insulin lispro-aabc injection, 100 units/mL and 200...(PR Newswire)

October 01, 2020
Dexcom Schedules Third Quarter 2020 Earnings Release and Conference Call for October 27, 2020 at 4:30 p.m. Eastern Time.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2020 financial results after market close on Tuesday, October 27, 2020. Management will hold a conference call to review the company's third quarter 2020...(BusinessWire)

September 24, 2020
Dexcom Signs Multi-Year Collaboration Agreement with the University of Virginia to Advance Type 1 and Type 2 Diabetes Research

DexCom, Inc. (NASDAQ:DXCM) today announced it has signed a five-year collaboration agreement with the University of Virginia to advance its research and development efforts on continuous glucose monitoring-based solutions. The research partnership...(BusinessWire)

September 22, 2020
Dexcom G6 Continuous Glucose Monitoring System Now Available at Veterans Affairs Pharmacies Across the United States

DexCom, Inc. (NASDAQ:DXCM) announced today the Dexcom G6 Continuous Glucose Monitoring (CGM) System is now available at Veterans Affairs (VA) pharmacies, improving access to CGM and empowering veterans with diabetes to better manage their condition...(BusinessWire)

September 16, 2020
Dexcom Announces First-Ever Registry Dedicated to Tracking Outcomes of In-Hospital Real-Time CGM Use in Response to the COVID-19 Pandemic

DexCom, Inc. (NASDAQ:DXCM), the leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today the first ever registry dedicated to tracking the outcomes of patients and healthcare professionals using CGM in...(BusinessWire)

September 04, 2020
Dexcom Announces Upcoming Virtual Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming virtual investor conferences: Steve Pacelli, Executive Vice President Strategy and Corporate Development, and Jereme Sylvain...(BusinessWire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.